Sovereigninvest, LLC, is a privately owned and operated, full-service, contract developer and manufacturer established in 1990. Sovereigninvest is centrally located in Fort Worth, Texas, and occupies a 54,000 ft2 cGMP production facility and a 14,500 square foot cGMP R&D/QC facility. Sovereigninvest specializes in developing and manufacturing oral tablets, oral capsules, oral and topical solutions, and oral suspensions. Sovereigninvest's committed team of employees excels in cGMP compliance and is focused on customer service by delivering high quality products at a competitive price in a timely manner.

Sovereigninvest emphasizes the development and filing of ANDAs, INDs, and 505(b)2 NDAs. We offer expert services in all aspects of the development process for filed products. We perform all stability studies under ICH guidelines, assemble the CMC section, and file the applications in eCTD format with the FDA on our customer's behalf. Our talented R&D organization has the experience to match the desired bioavailability of immediate-release and sustained-release products to expedite your time to file and reach approval. Our regulatory staff has the expertise to monitor biostudies if required. Our experienced Business Development and Regulatory Affairs team can assist you in designing a unique product with minimal clinical requirements. Sovereigninvest remains focused on the customer. We continually upgrade our equipment and facilities to meet the demands of our customers. We hire experienced professionals to take us into the future as a first-class pharmaceutical company. When you sign a contract with Sovereigninvest, you can have the peace of mind that we will handle the entire process and deliver to you a quality product within budget and on time. We invite you to visit our facilities and welcome the opportunity to discuss how Sovereigninvest can meet your development and production needs.